- Home
- FBRX vs MKTW Comparison
FBRX vs MKTW Comparison
Compare FBRX & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- MKTW
- Stock Information
- Founded
- FBRX N/A
- MKTW 1999
- Country
- FBRX United States
- MKTW United States
- Employees
- FBRX N/A
- MKTW N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- FBRX Health Care
- MKTW Technology
- Exchange
- FBRX Nasdaq
- MKTW Nasdaq
- Market Cap
- FBRX 35.3M
- MKTW 29.1M
- IPO Year
- FBRX N/A
- MKTW N/A
- Fundamental
- Price
- FBRX $5.97
- MKTW $13.55
- Analyst Decision
- FBRX Strong Buy
- MKTW
- Analyst Count
- FBRX 3
- MKTW 0
- Target Price
- FBRX $80.50
- MKTW N/A
- AVG Volume (30 Days)
- FBRX 32.5K
- MKTW 50.7K
- Earning Date
- FBRX 05-12-2025
- MKTW 05-14-2025
- Dividend Yield
- FBRX N/A
- MKTW 3.29%
- EPS Growth
- FBRX N/A
- MKTW 260.00
- EPS
- FBRX N/A
- MKTW 3.60
- Revenue
- FBRX N/A
- MKTW $408,701,000.00
- Revenue This Year
- FBRX N/A
- MKTW N/A
- Revenue Next Year
- FBRX N/A
- MKTW $15.73
- P/E Ratio
- FBRX N/A
- MKTW $3.85
- Revenue Growth
- FBRX N/A
- MKTW N/A
- 52 Week Low
- FBRX $4.11
- MKTW $9.08
- 52 Week High
- FBRX $28.68
- MKTW $34.60
- Technical
- Relative Strength Index (RSI)
- FBRX 42.87
- MKTW 61.74
- Support Level
- FBRX $5.25
- MKTW $12.76
- Resistance Level
- FBRX $7.67
- MKTW $14.53
- Average True Range (ATR)
- FBRX 0.92
- MKTW 1.34
- MACD
- FBRX 0.17
- MKTW 0.39
- Stochastic Oscillator
- FBRX 38.44
- MKTW 83.43
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.